Diploma in Infection Prevention & Control

Diploma in Infection Prevention & Control One-year online course in infection prevention and control offered by the University of Hyderabad in

A recent study shows alarming rates of carbapenem-resistant Klebsiella pneumoniae among newborns in NICUs, significantly...
25/09/2025

A recent study shows alarming rates of carbapenem-resistant Klebsiella pneumoniae among newborns in NICUs, significantly raising the risk of infections and prolonged hospital stays.

Conducted by icddr,b and presented by Dr. Fahmida Chowdhury, the study involved 423 neonates, revealing that 81% carried CR-Kpn, with 70% acquiring it after 48 hours of hospitalization. This highlights the urgent issue of antimicrobial resistance (AMR) in hospital environments. Additionally, the findings indicated that 60% of patients in adult ICUs were colonized with Carbapenem-Resistant Enterobacterales (CRE). The study tracked mother-child pairs, indicating that 40% of infants were colonized with CRE and that early antibiotic exposure (over 80% by their first birthday) could influence microbiome health negatively. Importantly, infection prevention and control (IPC) measures, including enhanced hand hygiene and environmental cleaning, demonstrated a significant operational impact in mitigating the colonization of resistant organisms, showcasing practical solutions even in resource-limited settings.

For further insights into these critical findings and the implications for infection prevention, please visit www.onehealthupdate.com. https://go.upcontent.com/63c4fc96-6db1-4c61-8e86-89535a1ed212

Recent studies underscore the importance of understanding glycemic control challenges in critically ill patients, partic...
24/09/2025

Recent studies underscore the importance of understanding glycemic control challenges in critically ill patients, particularly regarding infection management and outcomes.

The reviewed articles encompass diverse topics related to blood glucose levels and their implications in critical care settings. They highlight the significant role of hyperglycemia in sepsis, linking it to adverse outcomes and complications. Studies also explore the molecular mechanisms underlying inflammation, insulin resistance, and their interactions with glucose variability. Notably, research illustrates how both hyperglycemia and glycemic fluctuations can affect mortality rates among critically ill patients. The creation of predictive scoring systems, such as the PRESEP Score, is emphasized for the early identification of septic patients, improving patient management strategies.

To delve deeper into the intricacies of glycemic management in intensive care and its relevance to sepsis and infection control, visit www.onehealthupdate.com for comprehensive insights and resources. https://go.upcontent.com/9acb1aee-45a7-4b3f-a561-9a3119bba27c

A recent study indicates that metformin, an accessible diabetes medication, may significantly reduce the risk of Long CO...
22/09/2025

A recent study indicates that metformin, an accessible diabetes medication, may significantly reduce the risk of Long COVID among overweight individuals.

In a comprehensive retrospective analysis published in Clinical Infectious Diseases, researchers assessed over 1.8 million data points from more than 624,000 UK individuals. The findings revealed that overweight or obese patients who started metformin within 90 days following a COVID-19 diagnosis experienced a striking 64% decrease in their likelihood of acquiring Long COVID compared to those not treated with the drug. The study underscores a potential preventive avenue using a commonly prescribed and cost-effective medication to address Long COVID, which has become a widespread concern affecting millions since the pandemic began.

For further insights and in-depth information, please visit www.onehealthupdate.com. https://go.upcontent.com/9bc1b306-1953-46ed-987e-b7b8e4c377a6

The review article from Queen's University Belfast highlights the growing concern of antifungal resistance in yeast path...
21/09/2025

The review article from Queen's University Belfast highlights the growing concern of antifungal resistance in yeast pathogens due to dual azole use in agriculture, calling for urgent action within a One Health framework.

Invasive fungal infections driven by pathogenic yeasts are increasingly becoming a global health crisis. The article critically analyzes the impact of widespread agricultural use of azole fungicides, identifying it as a primary factor accelerating antifungal resistance. By dissecting the shared molecular mechanisms and resistance pathways, the authors reveal alarming cross-resistance between environmental fungicides and clinical azoles. The review provides insights into environmental reservoirs of yeast pathogens, emphasizing that agricultural soils, wastewater, and the food supply chain are burdened by persistent azole contamination, which fosters resistance evolution. With antifungal treatment options decreasing and resistance linked to rising morbidity and mortality rates globally, the authors call for integrated strategies involving surveillance, stewardship, and environmental interventions to preserve antifungal efficacy and tackle this pressing health threat.

To dive deeper into this crucial topic on antifungal resistance and its implications for public health and environmental stewardship, visit www.onehealthupdate.com. https://go.upcontent.com/e9c480fd-2296-4415-acec-c12b5e2f1078

COVID-19 vaccines have been updated to counter evolving variants, with new approvals aimed at enhancing protection for v...
20/09/2025

COVID-19 vaccines have been updated to counter evolving variants, with new approvals aimed at enhancing protection for vulnerable populations.

In response to the ongoing challenges posed by COVID-19, particularly the emergence of new variants, the US FDA has approved three updated vaccines: Moderna for those six months and older, Pfizer for ages five and older, and Novavax for individuals 12 and up. These vaccines protect against the LP.8.1 strain, a descendant of the Omicron variant, and offer expectations of shielding against the dominant XFG strain causing most infections currently. Eligibility has evolved, primarily targeting older adults and younger individuals with underlying health conditions that heighten the risk of severe illness. The Advisory Committee on Immunization Practices (ACIP) meeting on September 18 is expected to clarify high-risk conditions and insurance coverage for the vaccines. Additionally, while healthy individuals can technically receive the updated vaccines, practical barriers such as the need for prescriptions and cost considerations pose access challenges, especially for uninsured populations. Experts emphasize the importance of these vaccines in safeguarding high-risk groups and minimizing severe COVID outcomes.

For more detailed insights into the updated vaccines and guidelines, please visit www.onehealthupdate.com. https://go.upcontent.com/a76d00ef-ccf7-4e03-b74e-773ed13f027a

European health officials have raised alarms about the rapid spread of multidrug-resistant Candida auris in hospitals, p...
19/09/2025

European health officials have raised alarms about the rapid spread of multidrug-resistant Candida auris in hospitals, particularly in Spain, Greece, Italy, Romania, and Germany.

The European Centre for Disease Prevention and Control (ECDC) has reported a significant rise in C. auris cases in EU/EEA countries, with over half of the 4,012 diagnosed instances occurring in 2022 and 2023 alone. The rapid dissemination of this yeast, initially identified in Japan in 2009, poses a substantial threat to critically ill and immunocompromised patients due to its high mortality rates—ranging from 29% to 62%. The yeast's resistance to antifungal medications, particularly fluconazole, along with its ability to persist on surfaces in healthcare settings, complicates containment efforts. Alarmingly, many countries lack systematic surveillance, which may underrepresent the scale of the problem.

The 2024 ECDC survey highlights our vulnerabilities and underscores the urgent need for improved national preparedness, including better surveillance and specific infection prevention guidelines. With 4,514 cases reported in the US in 2023, the rise of C. auris is not limited to Europe, sparking concern about implications for global health trends.

For a more comprehensive understanding of this critical issue, please visit www.onehealthupdate.com. https://go.upcontent.com/ea35e429-b273-4f6d-98a7-01f0ff3a076f

Wenjun Zhang's groundbreaking research at UC Berkeley explores harnessing the oral microbiome to combat tooth decay thro...
18/09/2025

Wenjun Zhang's groundbreaking research at UC Berkeley explores harnessing the oral microbiome to combat tooth decay through beneficial bacteria.

Zhang's team is studying the interactions within the oral microbiome, focusing on the metagenome—the collective DNA of oral bacteria. By investigating specific gene clusters, they discovered a sticky molecule-producing gene present in some strains of cavity-causing bacteria, such as Streptococcus mutans. Rather than only targeting harmful bacteria, Zhang proposes enhancing the adhesion capabilities of beneficial bacteria like Streptococcus salivarius to outcompete their harmful counterparts. This innovative approach aims to reshape the oral microbiome, decreasing cavities and promoting oral health. Zhang envisions a future where advanced understanding of specialized metabolites could lead to novel strategies for maintaining oral hygiene, although brushing remains vital for now.

For more insights into this exciting research and its implications for personal and public health, visit www.onehealthupdate.com. https://go.upcontent.com/c85a6bd4-fd2f-4164-9e85-8353640bcf62

Recent research has revealed new, genetically distinct microbial species thriving in Antarctica's subglacial lakes, show...
17/09/2025

Recent research has revealed new, genetically distinct microbial species thriving in Antarctica's subglacial lakes, showcasing their unique metabolic adaptations.

Scientists analyzed samples from Mercer Subglacial Lake, leading to the production of 1,374 single-cell amplified genomes (SAGs) that unveil a complex microbial community. These microorganisms exhibit remarkable metabolic flexibility, enabling them to thrive in isolated, oxygen-deprived environments. They rely on processes such as chemolithotropy, utilizing inorganic chemicals like reduced sulfur and iron, but can also switch to organic sources like sugars and fats when available. The phylogenetic analysis indicates these species are evolutionarily distinct from their marine and surface counterparts, underscoring their adaptability and resilience in harsh conditions beneath the Antarctic Ice Sheet.

For further insights into the remarkable adaptations of these microorganisms, visit www.onehealthupdate.com. https://go.upcontent.com/ad3fc198-5bb8-4506-a12f-49b678a7b6fd

Invasive fungal diseases (IFDs) significantly elevate mortality risk in patients with complicated alcohol-related hepati...
16/09/2025

Invasive fungal diseases (IFDs) significantly elevate mortality risk in patients with complicated alcohol-related hepatitis, as recent research has shown.

A comprehensive study analyzed 81,156 adults diagnosed with alcohol-related hepatitis in France from 2012 to 2021. Focusing on a subset with complicated alcohol-related hepatitis (CAH), the researchers found that IFDs occurred in 2.2% of these patients, compared to 0.3% in those without CAH. The study revealed that patients with IFDs had a survival rate of only 17.5% after 12 weeks, while those with bacterial pneumonia had a survival rate of 46.8%. Additionally, IFDs were linked to a more than fourfold increase in mortality risk, highlighting their critical impact compared to bacterial pneumonia, which elevated the risk modestly. The study emphasizes the urgent need for evidence-based guidelines for screening and antifungal prophylaxis in CAH patients, as bacterial pneumonia may indicate a risk for subsequent IFDs.

For further reading on this topic, please visit www.onehealthupdate.com. https://go.upcontent.com/f3e99d0e-af51-42ff-9b06-cbe84d26860e

In 2024, the United States experienced a 3.8% decrease in the death rate, with COVID-19 no longer among the top 10 leadi...
16/09/2025

In 2024, the United States experienced a 3.8% decrease in the death rate, with COVID-19 no longer among the top 10 leading causes of death for the first time in four years.

The latest report from the CDC's National Center for Health Statistics reveals that the overall death rate declined from 750.5 to 722 per 100,000 people, marking the lowest rate since 2020. Total deaths fell by approximately 20,000, from 3.09 million in 2023 to 3.07 million in 2024. Heart disease continues to hold the top position as the leading cause of death, followed by cancer and unintentional injuries, while su***de has replaced COVID-19 as the 10th leading cause. This change indicates a shifting landscape in public health concerns, as experts highlight the significance of addressing rising risks like obesity and drug overdose deaths, which fell by nearly 27% in 2024. For various demographic groups, there were notable decreases in death rates, with a particular emphasis on the need for preventative health measures focusing on lifestyle modifications and access to quality healthcare.

For details and a more comprehensive understanding of this topic, visit www.onehealthupdate.com. https://go.upcontent.com/feab261e-70e1-4380-92b3-d6ab253e2b15

Nipavirus infection is now classified as a first-class infectious disease in South Korea, reflecting heightened internat...
15/09/2025

Nipavirus infection is now classified as a first-class infectious disease in South Korea, reflecting heightened international concerns regarding its potential public health impact.

The Korea Centers for Disease Control and Prevention (KCDC) has revised its notification protocol for infectious diseases, marking the first update since the Infectious Disease Prevention and Management Act was enacted in 2020. This new classification requires immediate reporting and stringent public health measures for diagnosed and suspected Nipah virus cases. The Nipah virus, first identified in Malaysia in 1998, is a zoonotic disease associated with significant mortality, ranging from 40% to 75%. Its transmission stems from infected animals, particularly fruit bats and pigs, and can occur through direct human contact or contaminated food. Symptoms may present as fever and respiratory issues, often leading to severe neurological effects like encephalitis, potentially resulting in rapid deterioration.

While there have been no reported cases in South Korea, neighboring regions, especially India and Bangladesh, have seen fatalities linked to the virus. The KCDC has prepared diagnostic testing systems for incoming travelers and established quarantine protocols for individuals returning from areas with known outbreaks. The KCDC emphasizes the need for heightened vigilance among healthcare providers to report any suspected cases.

For more detailed insights and updates on this critical public health issue, please visit www.onehealthupdate.com. https://go.upcontent.com/10afc3e9-b0ef-4ecd-a3f4-37eb0f0f8f8d

🎓 Inspiring Guest Lecture Delivered Today!We extend our heartfelt gratitude to Prashant Purohit, MBBS, MD, FRCPath (Medi...
14/09/2025

🎓 Inspiring Guest Lecture Delivered Today!
We extend our heartfelt gratitude to Prashant Purohit, MBBS, MD, FRCPath (Medical Microbiology), Consultant at Sherwood Forest Hospitals NHS Foundation Trust, UK, for delivering an exceptionally insightful lecture on "From Culture to Control: Decoding Lab Reports for Smarter IPC Decisions."

Dr. Purohit masterfully connected laboratory reports to practical IPC decisions, making the session both enlightening and inspiring for our Diploma in Infection Prevention and Control (DIPC) cohort and alumni. His clarity and passion for the subject created a truly memorable learning experience that has equipped our participants with valuable takeaways to strengthen their infection control practice.

The session was expertly introduced by DR RANGA REDDY BURRI, President, Infection Control Academy of India (IFCAI), concluding remark done by
Prof. B.R. Shamanna, Program Coordinator – DIPC, University of Hyderabad and facilitated by Pranav Kumar.

Thank you to all participants who made this collaborative learning session between IFCAI and University of Hyderabad a great success.
Thank you Sanmed Healthcare for providing the virtual platform.

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

Address

Center For Distance And Virtual Learning Golden Threshold, Nampally Station Road, Abids
Hyderabad
500001

Opening Hours

Monday 10:30am - 4pm
Tuesday 10:30am - 4pm
Wednesday 10:30am - 4pm
Thursday 10:30am - 4pm
Friday 10:30am - 4pm
Saturday 10:30am - 4pm

Telephone

+914024600264

Website

Alerts

Be the first to know and let us send you an email when Diploma in Infection Prevention & Control posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Diploma in Infection Prevention & Control:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category